Karleen M. Oberton's most recent trade in Ametek Inc was a trade of 1,030 Common Stock done at an average price of $176.1 . Disclosure was reported to the exchange on March 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| AMETEK | Karleen M. Oberton | Director | Grant, award, or other acquisition of securities at price $ 176.08 per share. | 18 Mar 2025 | 1,030 | 5,940 (0%) | 0% | 176.1 | 181,362 | Common Stock |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.54 per share. | 14 Nov 2024 | 1,332 | 102,108 (0%) | 0% | 77.5 | 103,283 | Common Stock |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2024 | 28,047 | 28,047 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.76 per share. | 07 Nov 2024 | 12,598 | 93,993 (0%) | 0% | 78.8 | 992,218 | Common Stock |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2024 | 9,447 | 103,440 (0%) | 0% | - | Common Stock | |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.29 per share. | 07 Nov 2024 | 1,161 | 106,591 (0%) | 0% | 79.3 | 92,056 | Common Stock |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2024 | 23,710 | 107,752 (0%) | 0% | - | Common Stock | |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 80.56 per share. | 29 Aug 2024 | 52,679 | 84,042 (0%) | 0% | 80.6 | 4,243,662 | Common Stock |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Aug 2024 | 26,080 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.97 per share. | 29 Aug 2024 | 26,080 | 129,996 (0%) | 0% | 41.0 | 1,068,498 | Common Stock |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Aug 2024 | 6,725 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.85 per share. | 29 Aug 2024 | 6,725 | 136,721 (0%) | 0% | 40.8 | 274,716 | Common Stock |
| AMETEK | Karleen M. Oberton | Director | Grant, award, or other acquisition of securities at price $ 181.93 per share. | 19 Mar 2024 | 1,030 | 4,910 (0%) | 0% | 181.9 | 187,388 | Common Stock |
| Hologic | Oberton Karleen M. | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 75.00 per share. | 29 Jan 2024 | 14,940 | 103,916 (0%) | 0% | 75 | 1,120,500 | Common Stock |
| AMETEK | Karleen M. Oberton | Director | Grant, award, or other acquisition of securities at price $ 138.46 per share. | 22 Mar 2023 | 1,210 | 3,880 (0%) | 0% | 138.5 | 167,537 | Common Stock |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.93 per share. | 09 Nov 2022 | 15,145 | 117,863 (0%) | 0% | 75.9 | 1,149,960 | Common Stock |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.11 per share. | 09 Nov 2022 | 680 | 133,008 (0%) | 0% | 72.1 | 49,035 | Common Stock |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2022 | 21,743 | 21,743 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2022 | 7,565 | 134,376 (0%) | 0% | - | Common Stock | |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.71 per share. | 07 Nov 2022 | 688 | 133,688 (0%) | 0% | 73.7 | 50,712 | Common Stock |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2022 | 20,872 | 126,811 (0%) | 0% | - | Common Stock | |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 72.50 per share. | 01 Nov 2022 | 14,545 | 126,811 (0%) | 0% | 72.5 | 1,054,513 | Common Stock |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 7,389 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.64 per share. | 01 Nov 2022 | 7,389 | 141,356 (0%) | 0% | 37.6 | 278,122 | Common Stock |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 7,156 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.96 per share. | 01 Nov 2022 | 7,156 | 133,967 (0%) | 0% | 40.0 | 285,954 | Common Stock |
| AMETEK | Karleen M. Oberton | Director | Grant, award, or other acquisition of securities at price $ 134.69 per share. | 21 Mar 2022 | 1,280 | 2,670 (0%) | 0% | 134.7 | 172,403 | Common Stock |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.61 per share. | 11 Nov 2021 | 912 | 105,939 (0%) | 0% | 72.6 | 66,220 | Common Stock |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2021 | 23,775 | 23,775 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2021 | 7,029 | 107,531 (0%) | 0% | - | Common Stock | |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.26 per share. | 08 Nov 2021 | 680 | 106,851 (0%) | 0% | 71.3 | 48,457 | Common Stock |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2021 | 43,424 | 100,502 (0%) | 0% | - | Common Stock | |
| AMETEK | Karleen M. Oberton | Director | Grant, award, or other acquisition of securities at price $ 121.91 per share. | 11 Mar 2021 | 1,390 | 1,390 (0%) | 0% | 121.9 | 169,455 | Common Stock |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.63 per share. | 01 Dec 2020 | 317 | 57,078 (0%) | 0% | 69.6 | 22,073 | Common Stock |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2020 | 23,767 | 23,767 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2020 | 6,949 | 58,307 (0%) | 0% | - | Common Stock | |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.84 per share. | 09 Nov 2020 | 912 | 57,395 (0%) | 0% | 69.8 | 63,694 | Common Stock |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2020 | 16,941 | 51,358 (0%) | 0% | - | Common Stock | |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.21 per share. | 21 Sep 2020 | 15,000 | 43,956 (0%) | 0% | 26.2 | 393,150 | Common Stock |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Sep 2020 | 15,000 | 5,461 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 62.50 per share. | 21 Sep 2020 | 15,000 | 28,956 (0%) | 0% | 62.5 | 937,500 | Common Stock |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Sep 2020 | 5,461 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Karleen M. Oberton | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.21 per share. | 21 Sep 2020 | 5,461 | 34,417 (0%) | 0% | 26.2 | 143,133 | Common Stock |